Scarica l'app Stockscreener
0.44
104.65%
0.225
Pre-mercato:
.41
-0.03
-6.82%
Precedente Chiudi:
$0.215
Aprire:
$0.5423
Volume 24 ore:
371.91M
Relative Volume:
19.76
Capitalizzazione di mercato:
$18.39M
Reddito:
$20.27M
Utile/perdita netta:
$-63.80M
Rapporto P/E:
-0.2895
EPS:
-1.52
Flusso di cassa netto:
$-68.35M
1 W Prestazione:
+84.87%
1M Prestazione:
+41.25%
6M Prestazione:
+9.73%
1 anno Prestazione:
-58.88%
Intervallo 1D:
$0.3941
$0.556
Intervallo di 1 settimana:
$0.2106
$0.556
Portata 52W:
$0.1417
$1.27
Carisma Therapeutics Inc Stock (CARM) Company Profile
Nome
Carisma Therapeutics Inc
Settore
Industria
Telefono
(267) 491-6422
Indirizzo
3675 MARKET STREET, PHILADELPHIA
Confronta CARM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CARM
Carisma Therapeutics Inc
|
0.44 | 8.98M | 20.27M | -63.80M | -68.35M | -1.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
401.00 | 100.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.90 | 61.55B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.00 | 58.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
706.41 | 43.59B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.04 | 33.67B | 3.81B | -644.79M | -669.77M | -6.24 |
Carisma Therapeutics Inc Stock (CARM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-12-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-04-11 | Iniziato | BTIG Research | Buy |
| 2023-10-03 | Iniziato | CapitalOne | Overweight |
| 2023-07-06 | Iniziato | Evercore ISI | Outperform |
| 2023-05-31 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-05-24 | Iniziato | H.C. Wainwright | Buy |
| 2023-04-14 | Iniziato | Robert W. Baird | Outperform |
Mostra tutto
Carisma Therapeutics Inc Borsa (CARM) Ultime notizie
How to integrate Carisma Therapeutics Inc. into portfolio analysis tools2025 Analyst Calls & Daily Technical Forecast Reports - Newser
Will Carisma Therapeutics Inc. rebound enough to break evenJuly 2025 Update & AI Driven Stock Reports - Newser
CARISMA Therapeutics Plunges 10.68% as HealthCap VII Sells Shares - AInvest
What Fibonacci levels say about Carisma Therapeutics Inc. rebound2025 Market Outlook & Low Risk Profit Maximizing Plans - Newser
Relative strength of Carisma Therapeutics Inc. in sector analysisQuarterly Trade Report & Technical Entry and Exit Tips - Newser
Carisma Therapeutics Inc. stock prediction for this week2025 Performance Recap & Weekly High Momentum Picks - Newser
Will Carisma Therapeutics Inc. see short term momentumJuly 2025 Recap & Technical Buy Zone Confirmations - Newser
Carisma Therapeutics stock soars after merger agreement with Ocugen - Investing.com
Will Carisma Therapeutics Inc. price bounce be sustainableJuly 2025 Summary & Free Daily Entry Point Trade Alerts - Newser
Is Carisma Therapeutics Inc. building a consolidation baseBond Market & Long-Term Growth Plans - Newser
Carisma Therapeutics (CARM) Surges 118% on Merger Spark – What’s Next for This Biotech Cinderella? - AInvest
Nasdaq Down 1%; Signet Jewelers Earnings Top Views - Benzinga
Why Is Carisma Therapeutics Stock (CARM) Up 165% Today? - TipRanks
Will Carisma Therapeutics Inc. continue its uptrendMarket Growth Summary & Consistent Profit Focused Trading Strategies - Newser
Forecasting Carisma Therapeutics Inc. price range with options dataStop Loss & Daily Stock Trend Reports - Newser
Why Carisma Therapeutics Shares Are Trading Higher By 133%; Here Are 20 Stocks Moving Premarket - inkl
CARISMA Therapeutics Stock Soars 150.23% on Investor Optimism - AInvest
Published on: 2025-09-02 02:17:39 - Newser
Carisma Therapeutics Inc. stock retracement – recovery analysis2025 Winners & Losers & Fast Exit and Entry Strategy Plans - Newser
Carisma Therapeutics Inc. stock momentum explainedPortfolio Risk Summary & Safe Swing Trade Setup Alerts - Newser
Analyzing net buyer seller activity in Carisma Therapeutics Inc.Trade Volume Summary & Weekly Stock Breakout Alerts - Newser
Does Carisma Therapeutics Inc. qualify in momentum factor screeningEarnings Recap Summary & Precise Trade Entry Recommendations - Newser
Will Carisma Therapeutics Inc. stock recover after recent dropTrade Analysis Report & Low Drawdown Trading Strategies - Newser
Applying sector rotation models to Carisma Therapeutics Inc.July 2025 Rallies & Daily Chart Pattern Signals - Newser
Visual analytics tools that track Carisma Therapeutics Inc. performanceRisk Management & Advanced Technical Signal Analysis - Newser
Tick level data insight on Carisma Therapeutics Inc. volatilityMarket Risk Report & Fast Gain Stock Trading Tips - Newser
What the charts say about Carisma Therapeutics Inc. todayTrade Volume Report & Low Risk High Reward Ideas - Newser
Combining price and volume data for Carisma Therapeutics Inc.July 2025 Patterns & Capital Efficiency Focused Ideas - Newser
Halozyme Therapeutics Inc. stock volume spike explainedTrade Risk Assessment & Fast Gain Stock Tips - Newser
Applying Wyckoff theory to Carisma Therapeutics Inc. stockEarnings Risk Summary & Smart Investment Allocation Insights - Newser
What to expect from Carisma Therapeutics Inc. in the next 30 daysJuly 2025 Decliners & Free Daily Entry Point Trade Alerts - Newser
Building trade automation scripts for Carisma Therapeutics Inc.2025 Historical Comparison & Reliable Volume Spike Alerts - Newser
Carisma Therapeutics Inc. Bounces Off Moving Average Support getLinesFromResByArray error: size == 0 - thegnnews.com
Carisma Therapeutics Inc Azioni (CARM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):